Sigachi Industries, a prominent player in the pharmaceutical industry, has recently unveiled a strategic partnership with Saudi National Projects Investment Limited (SNP), a reputable advisory investment firm. Through their wholly owned subsidiary, Sigachi MENA FZCO, and SNP, they have jointly established Sigachi Arabia, with Sigachi MENA FZCO holding a substantial 75% stake and SNP owning the remaining 25%.

This joint venture will operate as a holding company, overseeing distinct entities dedicated to key sectors such as pharmaceuticals, food and nutrition, and operations and management (O&M). As part of its expansion plans, Sigachi Arabia is gearing up to establish a state-of-the-art manufacturing facility in Riyadh. This facility will not only cater to the local market but also serve the Gulf Cooperation Council (GCC) countries, enhancing Sigachi's regional presence.

Saudi National Projects Investment Limited brings extensive expertise to the table, offering comprehensive global and local insights to build strategic and profitable partnerships. The firm has developed innovative analytical frameworks tailored for businesses in Saudi Arabia and China. With a global team of skilled investment analysts and managers, SNP has successfully executed deals worth over USD 50 billion, providing end-to-end guidance and support for their partners.

In a recent development, Sigachi Industries diversified its portfolio by venturing into the active pharmaceutical ingredient (API) business. This strategic move involved acquiring a majority stake in Trimax Bio Sciences, a reputable API manufacturing firm.

Sigachi Industries' shares experienced a marginal 1% decrease, closing at Rs 38.25. This joint venture marks a significant milestone in Sigachi Industries' journey, signalling its intent to expand its global footprint and strengthen its position in the pharmaceutical industry.

Source: zeebiz.com